𝔖 Bobbio Scriptorium

✦ LIBER ✦

Superior antisecretory profile of the novel reversible gastric proton pump inhibitor BY841, compared to ranitidine

✍ Scribed by S. Postius; U. Bräuer; W. Kromer; Byk Gulden

Book ID: 118879456
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 157 KB
Volume: 108
Category: Article
ISSN: 0016-5085
DOI: 10.1016/0016-5085(95)23438-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, tolerability and effect on penta

Safety, tolerability and effect on pentagastrin-stimulated gastric acid output (PSAO) of the new reversible proton pump inhibitor BY841: B. Simon, P. Müller, M. Hartmann∗, R. Huber∗, H. Bliesath∗, R. Lühmann∗, W. Wurst∗, H.W. Radtke∗. Clinic Schwetzingen, Salem Clinic, Heidelberg and ∗Byk Gulden Pharmaceuticals, Konstanz, Germany

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 147 KB

First administration to man of the new r

First administration to man of the new reversible proton pump inhibitor BY841: Tolerability; safety and pH-metry: H. Fuder, M. Hartmann∗, W. Timmer, R. Lühmann∗, G. Wieckhorst, R. Huber∗, H. Bliesath∗, W. Wurst∗, S. Postius∗, H.W. Radtke∗, P.W. Lücker. Institut for Clin. Pharmacology, Grünstadt and ∗Byk Gulden, Konstanz, Germany

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 136 KB